In general, the Abridged Evaluation has simplified registration requirements compared to the Full Evaluation. This category is exempted from certain information in Part I ACTD and Process Validation Report as tabulated in the table below. In addition, Abridged Evaluation does not require Quality Control pre-registration documentation such as the protocol of analysis (PoA) and analytical method validation (AMV) report. However, PoA still needs to be submitted to NPRA for the purpose of post-market surveillance testing after the product is registered.
Other than these exemptions, the registration requirements of Abridged Evaluation are the same as Full Evaluation such as the PICS GMP, CPP for imported products, labeling, package insert/RiMUP, certificate of analysis, Zone IVb Stability Data etc.
Product Categories
|
Registration Requirement
|
Exemption
|
Generics, Non-Scheduled Poison (X), Full Evaluation
|
Part I ACTD
Part II ACTD
DP - BA/BE Study for MR only + lab evaluation
DS (unregulated API, minimum requirement)
|
DP – BA/BE Report requirement for IR
|
Generics, Non-Scheduled Poison (X), Abridged Evaluation
|
Part I ACTD
Part II ACTD
DP - BA/BE Study for MR only
DS (unregulated API, minimum requirement)
|
Part I ACTD – PD, PK, P&L
Lab evaluation - AMV Report, PoA
|
ACTD : ASEAN Common Technical Dossier
DP : Drug Product
DS : Drug Substance
MR : Modified Release Oral Dosage Form
IR : Immediate Release Oral Dosage Form
BA/BE : Bioavailability/Bioequivalence
PD : Pharmacodynamic
PK : Pharmacokinetic
P&L : Pregnancy and Lactation
PV : Process Validation
AMV : Analytical Method Validation
PoA : Protocol of Analysis